Related Experiment Video

Updated: Aug 11, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

Chronic relapsing axonal neuropathy responsive to intravenous immunoglobulin

B Katirji1

  • 1Department of Neurology, Case Western Reserve University, University Hospitals of Cleveland, OH 44106, USA.

Neurology
|June 1, 1997
PubMed

Abstract:

Chronic relapsing axonal neuropathy is uncommon. I describe a 68-year-old patient who responded rapidly and repeatedly to intravenous immunoglobulin treatment.

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Related Experiment Videos

Last Updated: Aug 11, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Articles linked to this work by shared authors, journal, and citation graph.

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Neurology·2009

Sensory Mononeuropathy Multiplex in Chronic Graft versus Host Disease.

Journal of clinical neuromuscular disease·2008

Inflammatory myopathy in hemiatrophy resulting from linear scleroderma.

Journal of clinical neuromuscular disease·2008

Lambert-eaton myasthenic syndrome: a harbinger to transitional cell carcinoma of the urinary bladder.

Journal of clinical neuromuscular disease·2008

Chronic ataxic neuropathy mimicking dorsal midbrain syndrome.

Journal of neurology, neurosurgery, and psychiatry·2007

Multifocal motor neuropathy presenting with respiratory failure.

Muscle & nerve·2000

DWI-Positive Lesions in Patients With Acute Intracerebral Hemorrhage: Associations With Cerebral Small Vessel Disease and Clinical Outcome.

Neurology·2026

National Trends in Medicare Charges and Reimbursement for Inpatient Neurologic Care, 2013-2023.

Neurology·2026

Analysis of Interindividual Lesion Progression Variability in Adult Cerebral Adrenoleukodystrophy.

Neurology·2026

Prediction of Long-Term Postsurgical Seizure Recurrence From MRI Brain Hub Disruption in Patients With Temporal Lobe Epilepsy.

Neurology·2026

Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology.

Neurology·2026

Blood-Based Biomarkers for Alzheimer Disease in Primary Care: The Gap Between Biology and Clinical Utility.

Neurology·2026

A Diagnostic Challenge: Uncovering Autoimmune Hepatitis Masked by Choledocholithiasis and Unsupervised Ivermectin Use.

Cureus·2026

[HIV-associated myopathy: a case report].

The Pan African medical journal·2026

Haemophagocytic Lymphohistiocytosis Following Ipilimumab and Nivolumab in Malignant Pleural Mesothelioma: A Case Report.

Cureus·2026

Cross-sectional imaging in an inferior vena cava agenesis associated with antiphospholipid syndrome, lower limb, and portomesenteric deep vein thrombosis and renal insufficiency in a young patient: A rare presentation.

Radiology case reports·2026

SOHO State of the Art Updates and Next Questions| Mediastinal Gray-zone Lymphoma: Novel Biologic Insights and Updates on How Best to Approach This Rare Entity.

Clinical lymphoma, myeloma & leukemia·2026

Exploring the relationship between natural and cryptic polyreactivity in human antibodies.

Molecular immunology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us